HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor

Simona Pavan, Daniele Musiani, Erica Torchiaro, Giorgia Migliardi, Marta Gai, Ferdinando Di Cunto, Jessica Erriquez, Martina Olivero, Maria Flavia Di Renzo

Research output: Contribution to journalArticlepeer-review


The hepatocyte growth factor (HGF) also known as scatter factor activates cancer cell invasion and metastasis. We show that in ovarian cancer cells HGF induced the phosphorylation of the small heat shock protein of 27 kDa (HSP27) by activating the p38MAPK. HSP27 is increased in many cancers at advanced stage including ovarian cancer and associated with cancer resistance to therapy and poor patients' survival. The phosphorylation of HSP27 regulates both its chaperone activity and its control of cytoskeletal stability. We show that HSP27 was necessary for the remodeling of actin filaments induced by HGF and that motility in vitro depended on the p38MAPK-MK2 axis. In vivo, HSP27 silencing impaired the ability of the highly metastatic, HGF-secreting ovarian cancer cells to give rise to spontaneous metastases. This was due to defective motility across the vessel wall and reduced growth. Indeed, HSP27 silencing impaired the ability of circulating ovarian cancer cells to home to the lungs and to form experimental hematogenous metastases and the capability of cancer cells to grow as subcutaneous xenografts. Moreover, HSP27 suppression resulted in the sensitization of xenografts to low doses of the chemotherapeutic paclitaxel, likely because HSP27 protected microtubules from bundling caused by the drug. Altogether, these data show that the HSP27 is required for the proinvasive and prometastatic activity of HGF and suggest that HSP27 might be not only a marker of progression of ovarian cancer, but also a suitable target for therapy. What's new? Hepatocyte growth factor, HGF, induces cancers to spread. Recently, researchers learned that it activates a small heat shock protein, HSP27, which is increased in advanced stage cancers, and associated with resistance to chemotherapy. In this paper, the authors showed that silencing HSP27 stopped ovarian cancer cells from metastasizing. Suppressing HSP27 also sensitized the tumors to Paclitaxel. The results show that HSP27 is important for metastasis and invasion, and could make a promising target for therapy.

Original languageEnglish
Pages (from-to)1289-1299
Number of pages11
JournalInternational Journal of Cancer
Issue number6
Publication statusPublished - Mar 15 2014


  • hepatocyte growth factor
  • HSP27
  • MET receptor
  • metastasis
  • ovarian cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor'. Together they form a unique fingerprint.

Cite this